Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development

Rui Lu, Ping Wang, Trevor Parton, Yang Zhou, Kaliopi Chrysovergis, Shira Rockowitz, Wei Yi Chen, Omar Abdel-Wahab, Paul A. Wade, Deyou Zheng, Gang Greg Wang

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

DNA methyltransferase 3A (DNMT3A) is frequently mutated in hematological cancers; however, the underlying oncogenic mechanism remains elusive. Here, we report that the DNMT3A mutational hotspot at Arg882 (DNMT3AR882H) cooperates with NRAS mutation to transform hematopoietic stem/progenitor cells and induce acute leukemia development. Mechanistically, DNMT3AR882H directly binds to and potentiates transactivation of stemness genes critical for leukemogenicity including Meis1, Mn1, and Hoxa gene cluster. DNMT3AR882H induces focal epigenetic alterations, including CpG hypomethylation and concurrent gain of active histone modifications, at cis-regulatory elements such as enhancers to facilitate gene transcription. CRISPR/Cas9-mediated ablation of a putative Meis1 enhancer carrying DNMT3AR882H-induced DNA hypomethylation impairs Meis1 expression. Importantly, DNMT3AR882H-induced gene-expression programs can be repressed through Dot1l inhibition, providing an attractive therapeutic strategy for DNMT3A-mutated leukemias.

Original languageEnglish (US)
Pages (from-to)92-107
Number of pages16
JournalCancer Cell
Volume30
Issue number1
DOIs
StatePublished - Jul 11 2016

Fingerprint

Epigenomics
Leukemia
Stem Cells
Hematopoietic Stem Cells
Gene Expression
Histone Code
Clustered Regularly Interspaced Short Palindromic Repeats
Multigene Family
Transcriptional Activation
Genes
Mutation
DNA
DNA methyltransferase 3A
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development. / Lu, Rui; Wang, Ping; Parton, Trevor; Zhou, Yang; Chrysovergis, Kaliopi; Rockowitz, Shira; Chen, Wei Yi; Abdel-Wahab, Omar; Wade, Paul A.; Zheng, Deyou; Wang, Gang Greg.

In: Cancer Cell, Vol. 30, No. 1, 11.07.2016, p. 92-107.

Research output: Contribution to journalArticle

Lu, R, Wang, P, Parton, T, Zhou, Y, Chrysovergis, K, Rockowitz, S, Chen, WY, Abdel-Wahab, O, Wade, PA, Zheng, D & Wang, GG 2016, 'Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development', Cancer Cell, vol. 30, no. 1, pp. 92-107. https://doi.org/10.1016/j.ccell.2016.05.008
Lu, Rui ; Wang, Ping ; Parton, Trevor ; Zhou, Yang ; Chrysovergis, Kaliopi ; Rockowitz, Shira ; Chen, Wei Yi ; Abdel-Wahab, Omar ; Wade, Paul A. ; Zheng, Deyou ; Wang, Gang Greg. / Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development. In: Cancer Cell. 2016 ; Vol. 30, No. 1. pp. 92-107.
@article{87ffc1efce534a85a16964f255aecf3e,
title = "Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development",
abstract = "DNA methyltransferase 3A (DNMT3A) is frequently mutated in hematological cancers; however, the underlying oncogenic mechanism remains elusive. Here, we report that the DNMT3A mutational hotspot at Arg882 (DNMT3AR882H) cooperates with NRAS mutation to transform hematopoietic stem/progenitor cells and induce acute leukemia development. Mechanistically, DNMT3AR882H directly binds to and potentiates transactivation of stemness genes critical for leukemogenicity including Meis1, Mn1, and Hoxa gene cluster. DNMT3AR882H induces focal epigenetic alterations, including CpG hypomethylation and concurrent gain of active histone modifications, at cis-regulatory elements such as enhancers to facilitate gene transcription. CRISPR/Cas9-mediated ablation of a putative Meis1 enhancer carrying DNMT3AR882H-induced DNA hypomethylation impairs Meis1 expression. Importantly, DNMT3AR882H-induced gene-expression programs can be repressed through Dot1l inhibition, providing an attractive therapeutic strategy for DNMT3A-mutated leukemias.",
author = "Rui Lu and Ping Wang and Trevor Parton and Yang Zhou and Kaliopi Chrysovergis and Shira Rockowitz and Chen, {Wei Yi} and Omar Abdel-Wahab and Wade, {Paul A.} and Deyou Zheng and Wang, {Gang Greg}",
year = "2016",
month = "7",
day = "11",
doi = "10.1016/j.ccell.2016.05.008",
language = "English (US)",
volume = "30",
pages = "92--107",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development

AU - Lu, Rui

AU - Wang, Ping

AU - Parton, Trevor

AU - Zhou, Yang

AU - Chrysovergis, Kaliopi

AU - Rockowitz, Shira

AU - Chen, Wei Yi

AU - Abdel-Wahab, Omar

AU - Wade, Paul A.

AU - Zheng, Deyou

AU - Wang, Gang Greg

PY - 2016/7/11

Y1 - 2016/7/11

N2 - DNA methyltransferase 3A (DNMT3A) is frequently mutated in hematological cancers; however, the underlying oncogenic mechanism remains elusive. Here, we report that the DNMT3A mutational hotspot at Arg882 (DNMT3AR882H) cooperates with NRAS mutation to transform hematopoietic stem/progenitor cells and induce acute leukemia development. Mechanistically, DNMT3AR882H directly binds to and potentiates transactivation of stemness genes critical for leukemogenicity including Meis1, Mn1, and Hoxa gene cluster. DNMT3AR882H induces focal epigenetic alterations, including CpG hypomethylation and concurrent gain of active histone modifications, at cis-regulatory elements such as enhancers to facilitate gene transcription. CRISPR/Cas9-mediated ablation of a putative Meis1 enhancer carrying DNMT3AR882H-induced DNA hypomethylation impairs Meis1 expression. Importantly, DNMT3AR882H-induced gene-expression programs can be repressed through Dot1l inhibition, providing an attractive therapeutic strategy for DNMT3A-mutated leukemias.

AB - DNA methyltransferase 3A (DNMT3A) is frequently mutated in hematological cancers; however, the underlying oncogenic mechanism remains elusive. Here, we report that the DNMT3A mutational hotspot at Arg882 (DNMT3AR882H) cooperates with NRAS mutation to transform hematopoietic stem/progenitor cells and induce acute leukemia development. Mechanistically, DNMT3AR882H directly binds to and potentiates transactivation of stemness genes critical for leukemogenicity including Meis1, Mn1, and Hoxa gene cluster. DNMT3AR882H induces focal epigenetic alterations, including CpG hypomethylation and concurrent gain of active histone modifications, at cis-regulatory elements such as enhancers to facilitate gene transcription. CRISPR/Cas9-mediated ablation of a putative Meis1 enhancer carrying DNMT3AR882H-induced DNA hypomethylation impairs Meis1 expression. Importantly, DNMT3AR882H-induced gene-expression programs can be repressed through Dot1l inhibition, providing an attractive therapeutic strategy for DNMT3A-mutated leukemias.

UR - http://www.scopus.com/inward/record.url?scp=84979781455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979781455&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2016.05.008

DO - 10.1016/j.ccell.2016.05.008

M3 - Article

C2 - 27344947

AN - SCOPUS:84979781455

VL - 30

SP - 92

EP - 107

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 1

ER -